New Research Development from 2010 to 2026
| BBAL Stock | USD 0.0001 0.00 0.00% |
Research Development | First Reported 2002-03-31 | Previous Quarter 68.9 K | Current Value 99.8 K | Quarterly Volatility 304.2 K |
Check New York financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among New York's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 10.2 M or Total Revenue of 44.6 M, as well as many indicators such as Price To Sales Ratio of 0.0454, Dividend Yield of 0.0015 or Days Sales Outstanding of 87.7. New financial statements analysis is a perfect complement when working with New York Valuation or Volatility modules.
New | Research Development | Build AI portfolio with New Stock |
Latest New York's Research Development Growth Pattern
Below is the plot of the Research Development of New York Health over the last few years. It is New York's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in New York's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
New Research Development Regression Statistics
| Arithmetic Mean | 691,685 | |
| Geometric Mean | 681,727 | |
| Coefficient Of Variation | 19.96 | |
| Mean Deviation | 83,385 | |
| Median | 648,759 | |
| Standard Deviation | 138,027 | |
| Sample Variance | 19.1B | |
| Range | 552.3K | |
| R-Value | 0.09 | |
| Mean Square Error | 20.2B | |
| R-Squared | 0.01 | |
| Significance | 0.74 | |
| Slope | 2,419 | |
| Total Sum of Squares | 304.8B |
New Research Development History
About New York Financial Statements
New York investors utilize fundamental indicators, such as Research Development, to predict how New Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 583.9 K | 1.1 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of New York Correlation against competitors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of New York. If investors know New will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about New York listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of New York Health is measured differently than its book value, which is the value of New that is recorded on the company's balance sheet. Investors also form their own opinion of New York's value that differs from its market value or its book value, called intrinsic value, which is New York's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because New York's market value can be influenced by many factors that don't directly affect New York's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between New York's value and its price as these two are different measures arrived at by different means. Investors typically determine if New York is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, New York's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.